These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 24183309)

  • 41. Synonymous mutations in RNASEH2A create cryptic splice sites impairing RNase H2 enzyme function in Aicardi-Goutières syndrome.
    Rice GI; Reijns MA; Coffin SR; Forte GM; Anderson BH; Szynkiewicz M; Gornall H; Gent D; Leitch A; Botella MP; Fazzi E; Gener B; Lagae L; Olivieri I; Orcesi S; Swoboda KJ; Perrino FW; Jackson AP; Crow YJ
    Hum Mutat; 2013 Aug; 34(8):1066-70. PubMed ID: 23592335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel RNASEH2B splice site mutation responsible for Aicardi-Goutieres syndrome in the Faroe Islands.
    Ostergaard E; Joensen F; Sundberg K; Duno M; Hansen FJ; Batbayli M; Sørensen N; Born AP
    Acta Paediatr; 2012 Nov; 101(11):e509-13. PubMed ID: 22882256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aicardi-Goutières syndrome.
    Crow YJ
    Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case Report: Novel Compound Heterozygous
    Garau J; Masnada S; Dragoni F; Sproviero D; Fogolari F; Gagliardi S; Izzo G; Varesio C; Orcesi S; Veggiotti P; Zuccotti GV; Pansarasa O; Tonduti D; Cereda C
    Front Immunol; 2021; 12():672952. PubMed ID: 33981319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral arterial stenoses and stroke: novel features of Aicardi-Goutières syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression.
    Thiele H; du Moulin M; Barczyk K; George C; Schwindt W; Nürnberg G; Frosch M; Kurlemann G; Roth J; Nürnberg P; Rutsch F
    Hum Mutat; 2010 Nov; 31(11):E1836-50. PubMed ID: 20842748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A possible genotype-phenotype correlation in Ashkenazi-Jewish individuals with Aicardi-Goutières syndrome associated with SAMHD1 mutation.
    Straussberg R; Marom D; Sanado-Inbar E; Lakovsky Y; Horev G; Shalev SA; Lev D; Lerman-Sagie T; Leshinsky-Silver E
    J Child Neurol; 2015 Mar; 30(4):490-5. PubMed ID: 25246298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis.
    Galli J; Gavazzi F; De Simone M; Giliani S; Garau J; Valente M; Vairo D; Cattalini M; Mortilla M; Andreoli L; Badolato R; Bianchi M; Carabellese N; Cereda C; Ferraro R; Facchetti F; Fredi M; Gualdi G; Lorenzi L; Meini A; Orcesi S; Tincani A; Zanola A; Rice G; Fazzi E;
    Medicine (Baltimore); 2018 Dec; 97(52):e13893. PubMed ID: 30593198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroradiologic patterns and novel imaging findings in Aicardi-Goutières syndrome.
    La Piana R; Uggetti C; Roncarolo F; Vanderver A; Olivieri I; Tonduti D; Helman G; Balottin U; Fazzi E; Crow YJ; Livingston J; Orcesi S
    Neurology; 2016 Jan; 86(1):28-35. PubMed ID: 26581299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Goutières Syndrome.
    Gray EE; Treuting PM; Woodward JJ; Stetson DB
    J Immunol; 2015 Sep; 195(5):1939-43. PubMed ID: 26223655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Phenotypic variations in Aicardi-Goutieres syndrome caused by RNASEH2B gene mutations: report of two new cases].
    Ortiz-Madinaveitia S; Conejo-Moreno D; López-Pisón J; Peña-Segura JL; Serrano-Madrid ML; Durán-Palacios IC; Peláez-Cabo P
    Rev Neurol; 2016 Feb; 62(4):165-9. PubMed ID: 26860721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical Aicardi-Goutieres syndrome: is the WRN locus a modifier?
    Lessel D; Saha B; Hisama F; Kaymakamzade B; Nurlu G; Gursoy-Özdemir Y; Thiele H; Nürnberg P; Martin GM; Kubisch C; Oshima J
    Am J Med Genet A; 2014 Oct; 164A(10):2510-3. PubMed ID: 24989684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
    Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ
    Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients.
    Al Mutairi F; Alfadhel M; Nashabat M; El-Hattab AW; Ben-Omran T; Hertecant J; Eyaid W; Ali R; Alasmari A; Kara M; Al-Twaijri W; Filimban R; Alshenqiti A; Al-Owain M; Faqeih E; Alkuraya FS
    Pediatr Neurol; 2018 Jan; 78():35-40. PubMed ID: 29239743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of a mutant
    Withers SE; Rowlands CF; Tapia VS; Hedley F; Mosneag IE; Crilly S; Rice GI; Badrock AP; Hayes A; Allan SM; Briggs TA; Kasher PR
    Front Immunol; 2023; 14():1100967. PubMed ID: 36949945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bilateral striatal necrosis in two subjects with Aicardi-Goutières syndrome due to mutations in ADAR1 (AGS6).
    La Piana R; Uggetti C; Olivieri I; Tonduti D; Balottin U; Fazzi E; Orcesi S
    Am J Med Genet A; 2014 Mar; 164A(3):815-9. PubMed ID: 24376015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.
    Herold N; Rudd SG; Sanjiv K; Kutzner J; Myrberg IH; Paulin CBJ; Olsen TK; Helleday T; Henter JI; Schaller T
    Exp Hematol; 2017 Aug; 52():32-39. PubMed ID: 28502830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations.
    du Moulin M; Nürnberg P; Crow YJ; Rutsch F
    Proc Natl Acad Sci U S A; 2011 Jun; 108(26):E232; author reply E233. PubMed ID: 21633013
    [No Abstract]   [Full Text] [Related]  

  • 58. The eukaryotic elongation factor eEF1A1 interacts with SAMHD1.
    Morrissey C; Schwefel D; Ennis-Adeniran V; Taylor IA; Crow YJ; Webb M
    Biochem J; 2015 Feb; 466(1):69-76. PubMed ID: 25423367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1.
    Livingston JH; Lin JP; Dale RC; Gill D; Brogan P; Munnich A; Kurian MA; Gonzalez-Martinez V; De Goede CG; Falconer A; Forte G; Jenkinson EM; Kasher PR; Szynkiewicz M; Rice GI; Crow YJ
    J Med Genet; 2014 Feb; 51(2):76-82. PubMed ID: 24262145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variable clinical phenotype in two siblings with Aicardi-Goutières syndrome type 6 and a novel mutation in the ADAR gene.
    Schmelzer L; Smitka M; Wolf C; Lucas N; Tüngler V; Hahn G; Tzschach A; Di Donato N; Lee-Kirsch MA; von der Hagen M
    Eur J Paediatr Neurol; 2018 Jan; 22(1):186-189. PubMed ID: 29221912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.